Rome, Italy

Antonello Pessi

This inventor holds 28 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Peptide Therapeutics. Top assignees: Eniricerche S.p.a., Merck Sharp + Dohme Corp., Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Active years: 1987-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonello Pessi. Retrieved from https://idiyas.com/inventor/antonello-pessi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 132(Granted Patents)


Location History:

  • Pomezia, IT (2015)
  • Pommezia, IT (2017)
  • Rome, IT (1987 - 2020)
  • D'Europa, IT (2020 - 2022)

Company Filing History:


Years Active: 1987-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
GLP-1 Receptor
Glucagon
Oxyntomodulin
Antiviral Peptides
HCV NS3 Protease
Immunoenzymatic Methods
Farnesyl-Protein Transferase
Antimalarial Vaccines
Retro-Inverso Peptides
Chimeric Peptides
Polypeptide Composition
Synthetic Peptides
28 patents (USPTO):Explore Patents

Title: Antonello Pessi: Innovator in Pharmaceutical Sciences

Introduction

Antonello Pessi is a prominent inventor based in Rome, Italy, recognized for his significant contributions to the pharmaceutical field. With an impressive portfolio of 27 patents, Pessi has focused on innovations that advance therapeutic strategies, particularly in the treatment of diseases linked to cellular processes.

Latest Patents

Among his latest inventions, Pessi has developed long-acting co-agonists of the glucagon and GLP-1 receptors. These discoveries aim to enhance metabolic regulation and improve treatment for metabolic disorders. Additionally, he has introduced retro-inverso peptide inhibitors that target key cellular functions associated with tumor cell migration and metastatic processes. These peptides form the foundation for potential therapeutic compositions aimed at treating various conditions marked by increased cell motility and angiogenesis, such as tumors and chronic inflammation.

Career Highlights

Antonello Pessi has established a robust career through his work in notable companies, including Eniricerche S.p.a. and Merck Sharp & Dohme Corporation. His experiences at these organizations have played a pivotal role in shaping his innovative approaches to pharmaceuticals.

Collaborations

Throughout his career, Pessi has collaborated with esteemed colleagues, including Elisabetta Bianchi and Antonio S. Verdini. These partnerships have been crucial in pushing the boundaries of research and development, leading to impactful innovations in the field.

Conclusion

Antonello Pessi stands out as a leading inventor whose work continues to make significant strides in pharmaceutical science. His 27 patents reflect a commitment to enhancing disease treatment and improving patient outcomes through innovative solutions. As the field of pharmaceuticals evolves, Pessi's contributions will undoubtedly remain influential.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…